Ashton Thomas Private Wealth, LLC Amgen Inc Transaction History

Ashton Thomas Private Wealth, LLC

$2.84 Trillion
Q2 2025

A detailed history of Ashton Thomas Private Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 92,123 shares of AMGN stock, worth $27.1 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares

92,123

Previous 88,490 4.11%

Holding current value

$27.1 Million

Previous $27.6 Billion 6.7%

% of portfolio

0.91%

Previous 1.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 31, 2025	BUY	$262.28 - $309.85 $952,863 - $1.13 Million	3,633 Added 4.11%	92,123 $25.7 Billion
Q1 2025 May 15, 2025	BUY	$258.59 - $327.36 $309,015 - $391,195	1,195 Added 1.37%	88,490 $27.6 Billion
Q4 2024 Feb 06, 2025	BUY	$258.78 - $328.31 $1.06 Million - $1.34 Million	4,087 Added 4.91%	87,295 $22.8 Billion
Q3 2024 Nov 05, 2024	BUY	$309.38 - $337.38 $618 - $674	2 Added 0.0%	83,208 $26.8 Billion
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $542,578 - $659,375	2,065 Added 2.54%	83,206 $26 Billion
Q1 2024 Apr 19, 2024	BUY	$268.87 - $324.56 $4.15 Million - $5.01 Million	15,450 Added 23.52%	81,141 $23.1 Billion
Q4 2023 Apr 19, 2024	BUY	$255.7 - $288.46 $50,117 - $56,538	196 Added 0.3%	65,691 $18.9 Billion
Q3 2023 Apr 19, 2024	BUY	$218.65 - $271.46 $2.5 Million - $3.1 Million	11,438 Added 21.16%	65,495 $17.6 Billion
Q2 2023 Apr 22, 2024	BUY	$214.27 - $253.37 $1.39 Million - $1.64 Million	6,472 Added 11.09%	64,807 $14.4 Billion
Q1 2023 Apr 22, 2024	SELL	$225.79 - $275.2 $5.15 Million - $6.28 Million	-22,806 Reduced 28.11%	58,335 $14.1 Billion
Q4 2022 Apr 19, 2024	SELL	$229.03 - $291.01 $47,867 - $60,821	-209 Reduced 0.39%	54,057 $14.2 Billion
Q3 2022 Apr 19, 2024	SELL	$224.46 - $253.15 $13,467 - $15,189	-60 Reduced 0.11%	54,266 $12.2 Billion
Q2 2022 Apr 19, 2024	BUY	$230.71 - $256.74 $69,213 - $77,022	300 Added 0.56%	54,326 $13.2 Billion
Q1 2022 Apr 19, 2024	BUY	$219.27 - $242.57 $1.04 Million - $1.15 Million	4,742 Added 9.62%	54,026 $13.1 Billion
Q4 2021 Apr 19, 2024	BUY	$198.88 - $227.6 $400,146 - $457,931	2,012 Added 4.26%	49,284 $11.1 Billion
Q3 2021 Apr 19, 2024	BUY	$212.27 - $248.7 $492,466 - $576,984	2,320 Added 5.16%	47,272 $10.1 Billion
Q2 2021 Apr 19, 2024	BUY	$233.58 - $259.14 $547,511 - $607,424	2,344 Added 5.5%	44,952 $11 Billion
Q1 2021 Apr 19, 2024	BUY	$221.91 - $258.6 $992,603 - $1.16 Million	4,473 Added 11.73%	42,608 $10.6 Billion
Q4 2020 Apr 19, 2024	BUY	$216.38 - $257.67 $7.31 Million - $8.7 Million	33,765 Added 772.65%	38,135 $8.77 Billion
Q3 2020 Apr 19, 2024	SELL	$234.65 - $260.95 $1.09 Million - $1.21 Million	-4,626 Reduced 51.42%	4,370 $1.11 Billion
Q2 2020 Apr 19, 2024	BUY	$197.81 - $242.74 $50,045 - $61,413	253 Added 2.89%	8,996 $2.12 Billion
Q1 2020 Apr 19, 2024	BUY	$182.24 - $241.7 $779,804 - $1.03 Million	4,279 Added 95.86%	8,743 $1.77 Billion
Q4 2019 Apr 19, 2024	BUY	$189.21 - $243.2 $418,343 - $537,715	2,211 Added 98.14%	4,464 $1.08 Billion
Q3 2019 Apr 19, 2024	SELL	$174.11 - $208.62 $2,611 - $3,129	-15 Reduced 0.66%	2,253 $436 Million
Q2 2019 Apr 19, 2024	BUY	$166.7 - $195.41 $135,527 - $158,868	813 Added 55.88%	2,268 $418 Million
Q1 2019 Apr 19, 2024	BUY	$180.87 - $203.88 $263,165 - $296,645	1,455 New	1,455 $276 Million

Others Institutions Holding AMGN

# of Institutions

3,275

Shares Held

442M

Call Options Held

6.15M

Put Options Held

7.25M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashton Thomas Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ashton Thomas Private Wealth, LLC with notifications on news.

Account

Ashton Thomas Private Wealth, LLC Amgen Inc Transaction History